Conor Completes EuroSTAR Enrollment; DES Study Results Take Stage At ACC
This article was originally published in The Gray Sheet
Executive Summary
Conor Medsystem plans to begin enrollment for its drug-eluting stent CoSTAR II pivotal trial by mid-year